According to Elanco's latest financial reports and stock price the company's current Operating Margin is -2.33%. At the end of 2022 the company had an Operating Margin of -1.49%.
Year | Operating Margin | Change |
---|---|---|
2022 | -1.49% | -87.45% |
2021 | -11.90% | -42.04% |
2020 | -20.53% | -906.23% |
2019 | 2.55% | -31.56% |
2018 | 3.72% | -146.21% |
2017 | -8.05% | 947.2% |
2016 | -0.77% | -91.38% |
2015 | -8.92% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | -36.36% | 1,460.52% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | -8,391.15% | 360,035.19% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.